The elusive nature of intrinsic efficacy

被引:84
作者
Clarke, WP
Bond, RA
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
[2] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0165-6147(97)01138-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the discipline of pharmacology, drugs (ligands) are used as tools to elucidate the processes of biological systems. Because of this, pharmacologists strive to delineate all characteristics of drugs. Decades of research have resulted in the proposal that ligands possess two properties that are intrinsic to the ligand and are invariant of the system in which their effects are investigated. These properties are affinity (the capacity of a drug to bind to a receptor) and intrinsic efficacy (the capacity of a drug to activate or inactivate a receptor). Although affinity is a relatively easy parameter to measure with a variety of techniques, ways of quantifying intrinsic efficacy have remained elusive ever since its inception. Furthermore, recent evidence suggests that intrinsic efficacy might not be a single, ligand-dependent parameter but that agonists might have multiple intrinsic efficacies. William Clarke and Richard Bond discuss several reasons why the claim that intrinsic efficacy is a ligand-dependent parameter should be questioned, and the possible impact of these findings.
引用
收藏
页码:270 / 276
页数:7
相关论文
共 30 条
  • [1] ARIENS EJ, 1954, ARCH INT PHARMACOD T, V99, P32
  • [2] BERG KA, 1994, MOL PHARMACOL, V46, P477
  • [3] Berg KA, 1996, MOL PHARMACOL, V50, P1017
  • [4] BERG KA, IN PRESS MOL PHARM
  • [5] PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR
    BOND, RA
    LEFF, P
    JOHNSON, TD
    MILANO, CA
    ROCKMAN, HA
    MCMINN, TR
    APPARSUNDARAM, S
    HYEK, MF
    KENAKIN, TP
    ALLEN, LF
    LEFKOWITZ, RJ
    [J]. NATURE, 1995, 374 (6519) : 272 - 276
  • [6] BURGEN ASV, 1981, FED PROC, V40, P2723
  • [7] Chidiac P, 1996, MOL PHARMACOL, V50, P662
  • [8] CLARK AJ, 1937, HEFFNERS HDB D EXP P, V4
  • [9] CLARK AJ, 1937, HEFFTERS HDB EXPT PH, V4
  • [10] COSTA T, 1992, MOL PHARMACOL, V41, P549